Published in Cancer Epidemiol Biomarkers Prev on November 01, 2004
Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA (2008) 2.73
Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am J Hum Genet (2005) 1.35
Androgen receptor signaling and mutations in prostate cancer. Asian J Androl (2010) 1.27
Molecular pathology of prostate cancer. J Clin Pathol (2005) 1.22
Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene. Biol Psychiatry (2007) 1.12
The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men's Health Study. J Hum Genet (2008) 1.10
Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome. J Clin Endocrinol Metab (2008) 1.06
A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. J Clin Endocrinol Metab (2010) 1.04
Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial. J Urol (2010) 0.98
Benign prostatic hyperplasia: from bench to clinic. Korean J Urol (2012) 0.96
Molecular pathways in prostate cancer. Nephrourol Mon (2013) 0.92
East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians. Chin J Cancer (2011) 0.92
Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis. Mol Hum Reprod (2012) 0.87
Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomes. Can J Urol (2008) 0.86
Identification of a novel germline missense mutation of the androgen receptor in African American men with familial prostate cancer. Asian J Androl (2010) 0.86
Decision tree-based modeling of androgen pathway genes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2011) 0.86
Prostate cancer in South Africa: pathology based national cancer registry data (1986-2006) and mortality rates (1997-2009). Prostate Cancer (2014) 0.85
Comparison of androgen receptor CAG and GGN repeat length polymorphism in humans and apes. Primates (2006) 0.82
Involvement of different mechanisms for the association of CAG repeat length polymorphism in androgen receptor gene with prostate cancer. Am J Cancer Res (2014) 0.81
Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes. Am J Cancer Res (2013) 0.80
Androgen receptor polyglutamine repeat number: models of selection and disease susceptibility. Evol Appl (2012) 0.78
Influence of CAG Repeat Polymorphism on the Targets of Testosterone Action. Int J Endocrinol (2015) 0.78
The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population. Korean J Urol (2015) 0.75
Association of androgen receptor GGN repeat length polymorphism and male infertility in Khuzestan, Iran. Iran J Reprod Med (2015) 0.75
Androgen receptor gene polymorphisms and risk of prostate cancer: a meta-analysis. Sci Rep (2017) 0.75
CAG Repeat Number in the Androgen Receptor Gene and Prostate Cancer. Balkan J Med Genet (2012) 0.75
Association between polymorphic CAG repeat lengths in the androgen receptor gene and susceptibility to prostate cancer: A systematic review and meta-analysis. Medicine (Baltimore) (2017) 0.75
Shorter GGN Repeats in Androgen Receptor Gene Would Not Increase the Risk of Prostate Cancer. Technol Cancer Res Treat (2016) 0.75
Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med (2011) 6.34
Colloquium paper: genome-wide patterns of population structure and admixture among Hispanic/Latino populations. Proc Natl Acad Sci U S A (2010) 3.20
Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function. Nat Genet (2002) 3.10
Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol (2004) 2.82
The history of African gene flow into Southern Europeans, Levantines, and Jews. PLoS Genet (2011) 2.81
Abraham's children in the genome era: major Jewish diaspora populations comprise distinct genetic clusters with shared Middle Eastern Ancestry. Am J Hum Genet (2010) 2.54
Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer. Eur Urol (2006) 2.14
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol (2010) 1.98
Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance. Radiology (2007) 1.92
DREAM4: Combining genetic and dynamic information to identify biological networks and dynamical models. PLoS One (2010) 1.89
The clinical epidemiology of urachal carcinoma: results of a large, population based study. J Urol (2012) 1.88
A versatile statistical analysis algorithm to detect genome copy number variation. Proc Natl Acad Sci U S A (2004) 1.88
Contrasting patterns of Y chromosome variation in Ashkenazi Jewish and host non-Jewish European populations. Hum Genet (2004) 1.85
Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet (2012) 1.81
Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood (2011) 1.79
Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data. Neurourol Urodyn (2003) 1.78
Gene flow from North Africa contributes to differential human genetic diversity in southern Europe. Proc Natl Acad Sci U S A (2013) 1.77
Alcohol consumption and risk of prostate cancer in middle-aged men. Int J Cancer (2005) 1.69
Posterior tibial nerve stimulation in the treatment of urge incontinence. Neurourol Urodyn (2003) 1.67
TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.64
Discrepancy between clinical staging through bimanual palpation and pathological staging after cystectomy. Urol Oncol (2010) 1.63
Should we abandon the FISH test? Eur Urol (2007) 1.62
The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. Eur J Public Health (2010) 1.62
Ultrasound detection of rotator cuff tears: observer agreement related to increasing experience. AJR Am J Roentgenol (2010) 1.54
A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet (2012) 1.52
Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem (2005) 1.48
The predictive value of p53, p27(kip1), and alpha-catenin for progression in superficial bladder carcinoma. Eur Urol (2006) 1.45
Familial aggregation of urothelial cell carcinoma. Int J Cancer (2002) 1.43
Posterior tibial nerve stimulation in the treatment of idiopathic nonobstructive voiding dysfunction. Urology (2003) 1.43
Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis. Cancer (2003) 1.42
Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2010) 1.39
It's not a radical prostatectomy, it's a total prostatectomy. Eur Urol (2008) 1.39
A mutation of PCDH15 among Ashkenazi Jews with the type 1 Usher syndrome. N Engl J Med (2003) 1.38
PCAdmix: principal components-based assignment of ancestry along each chromosome in individuals with admixed ancestry from two or more populations. Hum Biol (2012) 1.37
Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk. Cancer Res (2005) 1.29
Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Res (2008) 1.28
Risk factors for hypospadias. Eur J Pediatr (2006) 1.27
Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands. Int J Cancer (2007) 1.23
Common variants in DGKK are strongly associated with risk of hypospadias. Nat Genet (2010) 1.23
Mutations in MAP3K1 cause 46,XY disorders of sex development and implicate a common signal transduction pathway in human testis determination. Am J Hum Genet (2010) 1.21
Founder mutations among the Dutch. Eur J Hum Genet (2004) 1.21
Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research. Am J Transl Res (2009) 1.17
Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer. Radiat Res (2008) 1.16
Consumers' desire towards current and prospective reproductive genetic testing. J Genet Couns (2009) 1.11
Increased resolution of Y chromosome haplogroup T defines relationships among populations of the Near East, Europe, and Africa. Hum Biol (2011) 1.10
Loss of mitogen-activated protein kinase kinase kinase 4 (MAP3K4) reveals a requirement for MAPK signalling in mouse sex determination. PLoS Biol (2009) 1.10
Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation. Eur J Hum Genet (2011) 1.09
Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease. Am J Clin Nutr (2013) 1.08
Relation of height, body mass, energy intake, and physical activity to risk of renal cell carcinoma: results from the Netherlands Cohort Study. Am J Epidemiol (2004) 1.08
Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression. Cancer Res (2011) 1.06
Variety in fruit and vegetable consumption and the risk of lung cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev (2010) 1.05
North African Jewish and non-Jewish populations form distinctive, orthogonal clusters. Proc Natl Acad Sci U S A (2012) 1.05
Changes in prostate shape and volume and their implications for radiotherapy after introduction of endorectal balloon as determined by MRI at 3T. Int J Radiat Oncol Biol Phys (2008) 1.04
Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy. Cancer Discov (2014) 1.03
Melanoma of unknown primary origin: a population-based study in the Netherlands. Eur J Cancer (2012) 1.03
Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiol Biomarkers Prev (2013) 1.02
Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk. Metabolism (2011) 1.02
Tumor suppressor function of androgen receptor coactivator ARA70alpha in prostate cancer. Am J Pathol (2010) 1.02
Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma. Clin Cancer Res (2009) 1.01
No increased risk of cancer after coal tar treatment in patients with psoriasis or eczema. J Invest Dermatol (2009) 1.00
Genetics of hypospadias: are single-nucleotide polymorphisms in SRD5A2, ESR1, ESR2, and ATF3 really associated with the malformation? J Clin Endocrinol Metab (2010) 0.99
Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer. Radiother Oncol (2013) 0.99
Continuous vs. intermittent androgen deprivation therapy for metastatic prostate cancer. Urol Oncol (2011) 0.99
Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population. Nephrol Dial Transplant (2011) 0.99
Glenohumeral joint injection: a comparative study of ultrasound and fluoroscopically guided techniques before MR arthrography. Eur Radiol (2008) 0.98
Factors affecting erectile function after radical retropubic prostatectomy: results from 1620 consecutive patients. BJU Int (2008) 0.98
No major association between TGFBR1*6A and prostate cancer. BMC Genet (2004) 0.98
The Inferelator 2.0: a scalable framework for reconstruction of dynamic regulatory network models. Conf Proc IEEE Eng Med Biol Soc (2009) 0.98
A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys (2012) 0.98
Cancer risk assessment using genetic panel testing: considerations for clinical application. J Genet Couns (2014) 0.98
A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer. Eur Radiol (2006) 0.96
Lack of major involvement of human uroplakin genes in vesicoureteral reflux: implications for disease heterogeneity. Kidney Int (2004) 0.96
Minor abnormalities of testis development in mice lacking the gene encoding the MAPK signalling component, MAP3K1. PLoS One (2011) 0.96
Fluid intake and the risk of urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer (2010) 0.95
Long-term risk of re-treatment of patients using alpha-blockers for lower urinary tract symptoms. J Urol (2002) 0.94
Detection of rotator cuff tears: the value of MRI following ultrasound. Eur Radiol (2009) 0.94
The effect of demographic and lifestyle changes on the burden of breast cancer in Iranian women: a projection to 2030. Breast (2012) 0.94
A KCNE2 mutation in a patient with cardiac arrhythmia induced by auditory stimuli and serum electrolyte imbalance. Cardiovasc Res (2007) 0.92
Fertility in men with testicular germ cell tumors. Fertil Steril (2003) 0.91
Carotenoid and vitamin intake, von Hippel-Lindau gene mutations and sporadic renal cell carcinoma. Cancer Causes Control (2007) 0.90
Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation. Hum Genet (2013) 0.90
Hypertension, antihypertensives and mutations in the Von Hippel-Lindau gene in renal cell carcinoma: results from the Netherlands Cohort Study. J Hypertens (2005) 0.90
Vegetable and fruit consumption and risk of renal cell carcinoma: results from the Netherlands cohort study. Int J Cancer (2005) 0.89
Health inequalities in the Netherlands: a cross-sectional study of the role of Type D (distressed) personality. BMC Public Health (2012) 0.89
Genome-wide association of single-nucleotide polymorphisms with weight loss outcomes after Roux-en-Y gastric bypass surgery. J Clin Endocrinol Metab (2013) 0.89
Reducing robotic prostatectomy costs by minimizing instrumentation. J Endourol (2014) 0.88
Posterior tibial nerve stimulation in the treatment of voiding dysfunction: urodynamic data. Neurourol Urodyn (2004) 0.88
Age at diagnosis and breast cancer survival in iran. Int J Breast Cancer (2012) 0.88
The length of positive surgical margins correlates with biochemical recurrence after radical prostatectomy. Histopathology (2010) 0.87
The effect of the ATG16L1 Thr300Ala polymorphism on susceptibility and outcome of patients with epithelial cell-derived thyroid carcinoma. Endocr Relat Cancer (2012) 0.87
Consumption of vegetables and fruit and the risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2009) 0.87
Does body mass index affect outcome after reconstruction of orthotopic neobladder? Urology (2007) 0.87
Segregation analysis of 389 Icelandic pedigrees with Breast and prostate cancer. Genet Epidemiol (2002) 0.87
Mutations in MAP3K1 tilt the balance from SOX9/FGF9 to WNT/β-catenin signaling. Hum Mol Genet (2013) 0.87
Urinary bladder cancer susceptibility markers. What do we know about functional mechanisms? Int J Mol Sci (2013) 0.86
Components of the plasminogen activator system and their complexes in renal cell and bladder cancer: comparison between normal and matched cancerous tissues. BJU Int (2008) 0.86
Urodynamic effects of alpha-adrenoceptor blockers: a review of clinical trials. Urology (2003) 0.86
A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer. J Urol (2013) 0.86
SRY gene expression in the ovotestes of XX true hermaphrodites. J Urol (2002) 0.85
Eliminate the term "superficial" bladder cancer. J Urol (2006) 0.85